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ABSTRACT
Hypoxia and inflammation are implicated in the episodic induction of heterotopic endochondral ossification (HEO); however, the
molecular mechanisms are unknown. HIF-1a integrates the cellular response to both hypoxia and inflammation and is a prime
candidate for regulating HEO.We investigated the role of hypoxia and HIF-1a in fibrodysplasia ossificans progressiva (FOP), themost
catastrophic form of HEO in humans. We found that HIF-1a increases the intensity and duration of canonical bone morphogenetic
protein (BMP) signaling through Rabaptin 5 (RABEP1)-mediated retention of Activin A receptor, type I (ACVR1), a BMP receptor, in the
endosomal compartment of hypoxic connective tissue progenitor cells from patients with FOP. We further show that early
inflammatory FOP lesions in humans and in a mouse model are markedly hypoxic, and inhibition of HIF-1a by genetic or
pharmacologic means restores canonical BMP signaling to normoxic levels in human FOP cells and profoundly reduces HEO in a
constitutively active Acvr1Q207D/+ mouse model of FOP. Thus, an inflammation and cellular oxygen-sensing mechanism that
modulates intracellular retention of a mutant BMP receptor determines, in part, its pathologic activity in FOP. Our study provides
critical insight into a previously unrecognized role of HIF-1a in the hypoxic amplification of BMP signaling and in the episodic
induction of HEO in FOP and further identifies HIF-1a as a therapeutic target for FOP and perhaps nongenetic forms of HEO.
© 2016 American Society for Bone and Mineral Research.
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Introduction
Heterotopic endochondral ossification (HEO)—the transfor-mation of skeletal muscle and soft connective tissue
into mature lamellar bone through an obligate cartilaginous
template—occurs sporadically in response to traumaorbygenetic
mutation in the rare, disabling autosomal dominant disorder,
fibrodysplasia ossificans progressiva (FOP; MIM 135100).(1,2) FOP
is caused by a recurrent heterozygous activating mutation of
activin receptor A, type I/activin-like kinase 2 (ACVR1/ALK2;
referred hereafter as ACVR1), a bone morphogenetic protein
(BMP) type I receptor, in all individuals with classic FOP.(3) The
canonical FOP mutation and all of the genetic variants reported
in humans exhibit loss of autoinhibition of BMP signaling.(4,5)
Regulated feedback in BMP type I receptors is required for the
spatial and temporal modulation of BMP signaling.(6)
Despite the occurrence of germline activating mutations of
ACVR1 in all FOP patients, individuals with FOP do not form
bone continuously but rather episodically and often following
trivial injury, a finding that suggests that trauma-related triggers
induce tissue metamorphosis in the setting of altered micro-
environmental thresholds.(7) FOP flare-ups are predictably
associated with inflammation,(1) a well-known cause of tissue
hypoxia.(8)
Hypoxia, the principal trigger of cellular oxygen sensors,
prolongs the activation of cell surface protein kinase
receptors by decelerating their endocytosis and degrada-
tion.(9) BMP receptors are cell surface protein kinases whose
signaling and degradation are mediated, in part, by distinct
endosomal pathways, a finding that has profound implica-
tions for their morphogenetic function.(6,9–12) Signaling can
be modulated by targeting active receptors for degradation
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or by dysregulating trafficking of receptors through the
endocytic pathway.(12,13)
The molecular response to hypoxia is controlled by the HIF
family of heterodimeric transcription factors composed of the
subunits HIF-1a and HIF-1b. HIF-1b is constitutively expressed
and stable. HIF-1a, in contrast, is oxygen sensitive and targeted
for ubiquitin-mediated degradation to experimentally unde-
tectable levels after oxygen-dependent prolyl-hydroxylation.(14)
In hypoxia, prolyl hydroxylases (PHDs) are inactivated; HIF-1a
escapes hydroxylation, is stabilized, rapidly accumulates in
the nucleus, recruits HIF1-b, and binds to the penta-nucleotide
hypoxia-responsive elements of target genes to regulate
glycolysis, cell survival, cell reprogramming, inflammation, and
angiogenesis.(9,15) HIF-1a and HIF-2a are closely related and
activate HRE-dependent gene expression, sharing several
common targets, such as VEGF, but also regulating distinct
transcriptional targets that may require unique transcriptional
cofactors.(16) HIF-1a is expressed ubiquitously, whereas HIF-2a
expression is more limited. Both HIF proteins appear to play
nonredundant roles in development, and in cancer cells have
differential effects on c-Myc activity.(16)
Stabilization of HIF-1a occurs as an adaptive response to
inflammation or hypoxia.(8) Posttranslational stabilization of
HIF-1a (by a tissue-specific knockout of the von Hippel-Lindau
gene) is sufficient to drive ectopic chondrogenesis in mouse
models.(17–19) Although dysregulated BMP signaling causes
robust HEO, the relationship between tissue hypoxia and BMP
signaling in the pathogenesis of HEO is unknown.
We speculated that the inflammatory microenvironment of
early FOP lesions might be hypoxic. We further reasoned that
molecular oxygen sensing during hypoxia might enhance BMP
signaling in FOP by stimulating retention of mutant ACVR1
(mACVR1, serine-threonine kinase) receptors in signaling endo-
somes similar to that which occurs with themutant EGF (tyrosine
kinase) receptors under hypoxic conditions during oncogene-
sis(9,20) To test this hypothesis, we evaluated early murine and
human FOP lesions for evidence of tissue hypoxia and HIF1-a
stabilization and then examined the effect of hypoxia on BMP
ligand-independent ACVR1 (R206H) activity in primary chondro-
osseous progenitor cells from FOP patients and controls. We
found that early inflammatory FOP lesions were profoundly
hypoxic and that hypoxia not only increased the intensity but
also prolonged the duration of BMP ligand-independent
signaling through an HIF-1a-mediatedmechanism that retained
ACVR1 in signaling endosomes. The endosomal retention of
ACVR1 under hypoxia was caused by HIF-1a transcriptional
downregulation of RABEP1, which encodes Rabaptin 5, a
neoplastic tumor suppressor gene that interacts to modulate
Rab5, a small GTPase that plays a critical role in endocytic
trafficking.(9,20,21) We further determined by both genetic and
pharmacologic means that attenuation of cellular oxygen
sensing restored BMP signaling to normoxic levels in FOP cells
and abrogated HEO in an Acvr1Q207D/+ mouse model of FOP.
Materials and Methods
Patient samples
Specimens from six FOP patients who underwent biopsy
for presumptive neoplasm before the definitive diagnosis of
FOP were obtained from superficial and deep back masses
later determined to be acute, early FOP lesions. To our
knowledge, this sample size represents all of the available
biopsy tissue for this ultra-rare disease. Normal muscle tissue
was obtained from the corresponding anatomic sites of four
age- and sex-matched unaffected individuals. Specimens were
also obtained from 8 patients with nonhereditary HEO owing to
trauma and spinal cord injury.
Tissue preparation and staining
Tissue samples were fixed in neutral buffered formalin, decal-
cified, infiltrated, embedded in paraffin, and sectioned at a
thickness of 5mm. Cut sampleswere deparaffinized, stainedwith
Harris hematoxylin solution, and counterstained with eosin
(H&E) by standard procedures. All stained slides were examined
under light microscopy for histological characteristics of FOP
lesion formation.(22) Distinct cellular elements/tissue types in the
same section were confirmed by two independent examiners
(RJP and FSK).
Animal models
A transgenic mouse model containing a constitutively active
(ca)ACVR1 allele flanked by loxP sites (caACVR1 mice) was
used in all animal experiments.(23,24) A 50-mL, 0.9% NaCl solution
containing adenovirus-Cre (5 1010 genome copies [GC] per
mouse; Penn Vector Core, University of Pennsylvania) to induce
expression of caACVR1 and cardiotoxin (100mL of a 10-mM
solution; Sigma-Aldrich, St. Louis, MO, USA) to induce an injury/
inflammatory response was injected into the hindlimb muscu-
lature of mice at 3 weeks of age. Tissues were recovered at 0, 2, 7,
and 14 days after injections.
Mice were bred in an animal biosafety level (ABSL) 1 facility
then transferred to an ABSL2 facility where procedures were
performed. Mice were housed as 1 or 2 mothers with litters
and then separated at weaning into cages of no more than
5 males or 5 females. Both males and females were used
for experiments. Other aspects of animal care and usage (eg,
light/dark cycle) were standard and performed by University
Laboratory Animal Resources (ULAR) in accordance with ULAR
policies and protocols.
Chondrogenesis pellet assay
Control or FOP stem cells from human exfoliated deciduous
teeth (SHED) were centrifuged in conical bottom 96-well
plates. Formed pellets were cultured in chondrogenic media
(CM) containing a-MEM, 1% ITS Premix (BD Biosciences,
San Jose, CA, USA), 50mg/ml L-proline, 0.1mM dexametha-
sone, 0.9mM sodium pyruvate, 50mg/mL ascorbate, and
antibiotics (PenStrep, Invitrogen/Life Technologies, Grand
Island, NY, USA) or CM plus 100 ng/mL BMP4 for 14 days.
Pellets were fixed in 4% paraformaldehyde and embedded in
paraffin. Sections (7mm thick) were deparaffinized in a graded
series of ethanol and stained with hematoxylin and eosin
(H&E), Safranin O, Alcian Blue (pH 1.0), and immunohisto-
chemically with collagen type II a (col2a; #ab34712, ABCAM,
Cambridge, MA, USA). Image J software (http://imagej.nih.gov/
ij/) was used to quantify pellet size and the ratio of
extracellular matrix area to cellular area.
Lentivirus infection of SHED cells
Human rabaptin 5 cloned into the lentiviral expression vector
pReceiver-Lv105 (GeneCopoeia, Rockville, MD, USA) was used
to generate lentivirus particles assembled in HEK293T cells.
Lentiviral particles were then used for polybrene-mediated
transduction using standard protocols. Two days after infection,
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control or FOP SHED cells were exposed to 1% O2 for 2 hours
and then protein extracted for Western blot analysis.
Adenovirus-Cre induction of MEFs
Mouse embryonic fibroblasts (MEFs) from conditional LoxP
HIF1-amice (HIF-1afl/flMEFs)(18) were infected at amultiplicity of
infection (MOI) of 100, with either Ad5CMVcre or Ad5CMVGFP
(Penn Vector Core, University of Pennsylvania), three successive
times over a 72-hour period. The addition of the former, but
not the latter, results in the induced deletion of floxed HIF-1a
in MEFs.
In vivo testing of HIF-1a inhibitors
caACVR1 mice were treated via gavage with either 25mg/kg of
apigenin (Sigma) in a vehicle containing 0.5% methyl cellulose
and 0.025% Tween 20 twice daily, 200mg/kg of imatinib
(SelleckBio, Houston, TX, USA) suspended in deionized water
twice daily, or with 10 mL/g of vehicle containing 0.5% methyl
cellulose and 0.025% Tween 20 twice daily. For treatment with
PX-478 (Bioorbyt, Berkeley, CA, USA), daily doses of 50mg/kg
and 100mg/kg in phosphate-buffered saline were given via
intraperitoneal injection. Mice were treated for 4 days before
and 14 days after induction of injury and recombination as
described above. Mice were euthanized 14 days after injection
with adenovirus-Cre/cardiotoxin, when 100% of animals repro-
ducibly form HEO at the injection site. Animals were randomly
assigned to the control or treatment groups in an unblinded
fashion.
Functional wire grasp test
Mobility in the left hindlimb of caACVR1 mice was assessed by
observation of their ability to grasp a wire using all four limbs.
Unimpaired mice grasp the wire with all four limbs (simulta-
neously), whereasmicewith impairedmobility of a joint can only
grasp the wire with three limbs simultaneously.
Micro-computed tomography
Micro-computed tomography (mCT) was performed on legs
from caACVR1 mice obtained 14 days after adenovirus-
Cre/cardiotoxin injection using a Scanco VivaCT 40 device
(Bruttisellen, Switzerland) to determine the volume of hetero-
topic bone and obtain a two-dimensional image of the medial
sagittal plane of each limb. Scanning was performed using a
source voltage of 55 kV, a source current of 142mA, and an
isotropic voxel size of 10.5mm. Bone was differentiated from
“non-bone” by an upper threshold of 1000 Hounsfield units
and a lower threshold of 150 Hounsfield units.
FKBP12 binding analysis
FKBP12 binding analysis was performed essentially as de-
scribed.(25) Briefly, total protein was isolated and quantified as
per Western blot analysis. Immunoprecipitation was carried out
using 500mg protein from each sample and 2mg ACVR1
antibody (Santa Cruz Biotechnology, Dallas, TX, USA) with
incubation at 4°C overnight, followed by incubation with 30mL
of Protein A/G agarose beads (Thermo Scientific Pierce,
Waltham, MA, USA) at 4°C for 1 hour and centrifugation at
800g for 5 minutes. The immunoprecipitated complex was
dissociated by 12% SDS-PAGE and Western blotting performed
using FKBP12 antibody (N19; Santa Cruz Biotechnology).
Cell culture, RNA isolation and real-time PCR, Western
blot analysis, immunocytochemistry, flow cytometry
Details of these standard procedures can be found in the
Supplemental Methods.
Statistics
Analysis of variance (ANOVA) was used with one or more of the
following factors: genotype, oxygen tension, and drug treat-
ment. The Bonferroni method for multiple comparisons was
used for post hoc analyses. Based on the estimated variability in
the amount of HEO formed by caACVR1 mice under induction
conditions, setting a¼ 0.05 and b¼ 0.20 (power of 0.80), a
minimum of 8 mice per experimental group were used to
test the effectiveness of HIF-1a inhibitors on HEO formation.
All statistical analyses were performed using GraphPad Prism
4.0 software (San Diego, CA, USA). The number of experimental
(biological) replicates are indicated in the figures or figure
legends, and for each biological replicate three in vitro technical
replicates were evaluated. Within experiments, variance
was similar between comparison groups and data met the
assumptions of the statistical tests. An adjusted p value of
< 0.05 was considered significant for all analyses. Data are
represented as mean standard error of the mean (SEM).
Study approval
Collection of specimens and mechanism of informed consent
were approved by the Institutional Review Board of the
University of Pennsylvania. Animal use was in accordance
with protocols approved by the University of Pennsylvania
Institutional Animal Care and Use Committee.
Results
Early inflammatory and prechondrogenic FOP patient
lesions are hypoxic
Lesion formation in FOP often occurs as the result of subtle soft
tissue trauma; therefore, biopsies are not obtained after a
diagnosis is made. However, rare glimpses into the histopa-
thology of early lesions have been afforded by misdiagnoses
of FOP. The earliest stages are composed of perivascular
inflammatory infiltrates, muscle degeneration, and fibroprolif-
eration.(22) We evaluated the hypoxic response in early FOP
lesions from six FOP patients who underwent diagnostic biopsy
for presumptive neoplasm before the correct diagnosis of
FOP. Nuclear localization of HIF-1a was present in prechon-
drogenic FOP lesions, indicative of a hypoxic response in
multiple cells types including inflammatory, endothelial,
muscle, and fibroproliferative cells (Fig. 1A, B). This response
is not detectable in normal muscle tissue from unaffected
individuals. In addition, we evaluated 13 distinct lesions from
8 patients with nonhereditary HEO owing to trauma and
spinal cord injury. All but one lesion (12/13) showed mature
heterotopic bone with bone marrow, likely reflecting surgical
bias to remove fairly mature HEO. One lesion showed
predominant evidence of slightly less mature bone with
cartilage bar remnants. Two lesions showed at least one area
of inflammation and fibroproliferation (but no cartilage). We
performed HIF1-a immunohistochemistry on the latter two
samples, and consistent with our findings in early FOP lesions,
these also show evidence of HIF1-a nuclear staining in
immature areas of lesion formation (Supplemental Fig. S1).
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Although the availability of antibodies with adequate
specificity against murine HIF-1a precluded us from conducting
the same analysis in a mouse model of HEO, we detected EF5, a
pentafluorintated derivative of etanidazole and a marker of
hypoxic cells, to examine hypoxia in early-stage lesions that
were induced by adenovirus-Cre and cardiotoxin in mice
constitutively active for ACVR1 (caACVR1), a murine model of
FOP-like heterotopic ossification.(23,24,26) The presence of EF5 in
areas of inflammation and fibroproliferation in day 2 and day 7
prechondrogenic lesions, respectively, indicated that hypoxia
was associated with the same pathological stages that
demonstrate a hypoxic response in lesional tissue from FOP
patients (Fig. 1C).
Because HIF-1a is ubiquitously expressed, including in early
FOP lesions, and its function in the hypoxic response is better
understood, we focused on its role in BMP signaling. We cannot
exclude a role for HIF-2a in this process.
The response to hypoxia in chondro-osseous progenitor
cells is regulated by the BMP signaling pathway
Hypoxia inhibits prolyl hydroxylases (PHDs), thus activating
HIF1-a. In SHED cells, a Tie2þ chondro-osseous progenitor cell
population,(27) hypoxia caused HIF1A nuclear translocation and
enhanced expression of HIF1-a target genes (Supplemental
Fig. S2). SHED cells represent a powerful in vitro model for
Fig. 1. Injury triggers hypoxia in early FOP lesions. (A) Nuclear localization of HIF-1a by immunohistochemistry in tissues sections from
unaffected individuals (n¼ 4) and those with FOP (n¼ 6). Magnified images of the indicated regions of interest are shown in the right-most panels. Scale
bar¼ 50 mm. Dashed circles delineate centralization of nuclei in degenerating muscle. (B) Quantification of HIF-1a-positive cells from normal human
muscle and stage-specific early FOP lesional tissue, expressed as the percentage of cells with nuclear HIF-1a (DAPI and HIF-1a co-localization).
(C) Identification of hypoxia in early FOP lesions induced by Adenovirus-Cre and cardiotoxin in a caACVR1 FOP-like mouse model (n¼ 3). The no
10 antibody (negative) control was performed on lesional tissue 7 days after injury. Scale bar¼ 100 mm.
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studying FOP because Tie2þmesenchymal stem cells have been
implicated in developing lesions, they are easily derived from
exfoliated primary teeth in a noninvasive manner that avoids
FOP exacerbations, and they reflect the identical stoichiometry
and genomic location of FOP mutations. We tested the
hypothesis that tissue hypoxia enhances BMP signaling through
mACVR1 using SHED cells isolated from FOP patients and
unaffected, age- and sex-matched individuals. Before choosing
SHED cell strains for use in experiments, we conducted an
analysis of 10 strains (5 FOP and 5 control) for Inhibitor of
Differentiation 1 (ID1) mRNA expression under normoxic
conditions. We chose representative cell strains based on the
median ID1 expression in each group and then used multiple
SHED cell isolates from these representative samples to conduct
future experiments. The variability in ID1 expression found
among SHED cell strains was similar to what we have found in
other cell models used to study FOP, including lymphoblastoid
cell lines; therefore, to minimize variability in SHED cell strains
based on the heterogeneous nature of donors, we conducted
all experiments using SHED cells that expressed the median
ID1 expression among FOP and control (unaffected) donors.
Supplemental Fig. S3 shows the distribution of ID1 expression
among all the SHED cell strains.
FOP and control SHED cells responded to hypoxia by elevated
levels of SMAD1/5/8 phosphorylation and ID1 mRNA after 2
hours (Fig. 2A, B). SMAD1/5/8 phosphorylation and ID1 mRNA
expression were significantly elevated in FOP cells compared
with control cells. FOP SHED cells continued to manifest
elevated SMAD1/5/8 phosphorylation and ID1 mRNA levels
after 24 and 6 hours, respectively, whereas control SHED cells at
these later time points had levels of ID1 mRNA comparable with
normoxic conditions (Fig. 2A, B). We also examined MSX2
mRNA expression as an additional target of BMP signaling and
obtained results similar to that with ID1 (Supplemental Fig. S4).
Using cobalt as a hypoxia mimetic recapitulated the effects of
hypoxia on BMP ligand-independent signaling in SHED cells
(Supplemental Fig. S5).
Although these experiments were performed in serum-free
media in the absence of exogenous BMP, we confirmed that
hypoxia-induced, enhanced early signaling through mACVR1 is
BMP ligand-independent by measuring SMAD1/5/8 phosphor-
ylation after treatment of SHED cells with Noggin. Fig. 2C, D
shows that Noggin did not mitigate ACVR1 signaling under
hypoxic conditions, in cells expressing mACVR1 or in control
cells. However, mACVR1 hypoxia-mediated signaling was
abrogated by Dorsomorphin, a BMP type I receptor inhibitor
(Fig. 2C, D) as well as LDN-193189, a selective inhibitor of BMP
type I receptor kinases (Supplemental Fig. S6). Similarly,
hypoxia-induced ID1 expression was minimized by Dorsomor-
phin. The p38 MAP kinase inhibitor SB203580 did not affect
signaling (Fig. 2C, D). Previous studies have shown that
treatment of SHED cells with inhibitors of extracellular signal-
regulated kinase (ERK) and inhibitors of c-jun N-terminal kinase
(JNK) had no effect on ID1 expression.(27)
Given these results, it is unlikely that enhanced BMP signaling
under hypoxia is because of modulation of soluble BMP
inhibitors, findings supported by our previous report.(27) We
also examined a possible role of FKBP12, a protein that is
required to maintain the ACVR1 receptor kinase in an auto-
inhibited state until activated by ligand. mACVR1 exhibited
lower FKBP12 binding in response to hypoxia compared with
wild-type receptor (Supplemental Fig. S7) and may in part
account for BMP ligand-independent signaling under hypoxia.
Hypoxia promotes chondrogenesis through BMP
signaling
We used SHED cells as a surrogate model system to assess
the obligate, pre-osseous chondrogenic phase of HEO in FOP.
We evaluated the ability of mACVR1 to promote chondrogenesis
in the absence of BMP and demonstrated that FOP SHED
cells, relative to control SHED cells, had an enhanced capacity
to differentiate into chondrocytes under hypoxic conditions
(Fig. 3). This was demonstrated by the nearly twofold larger
size of chrondrocyte pellets produced by FOP SHED cells
under hypoxia compared with control SHED cells or to FOP
SHED cells under normoxic conditions (Fig. 3A), and was
reflected in the greater amount of chondrocyte extracellular
matrix produced by hypoxic FOP SHED cells (Fig. 3B). Chron-
drocyte differentiation in pellets derived from SHED cells was
further confirmed by the upregulation of chrondrocyte markers
collagen 2a, Sox9, and aggrecan (ACAN) under hypoxic
conditions (Fig. 3C). Production of col2a is also enhanced by
the addition of BMP to control cells, and even more so by
addition to FOP cells (Supplemental Fig. S8), consistent with
the idea that the combination of hypoxia and increased
BMP signaling (via ACVR1 R206H mutation) could be driving
what is found in FOP chondrocyte pellets. These results
were not accounted for by increased proliferation of FOP
SHED cells under hypoxic conditions because there were
about 30% to 50% as many cells per unit area in chondrocyte
pellets derived from FOP SHED cells compared with controls
(53 8 to 74 11 cells/104 mm versus 148 22 to 161
23 cells/104mm).
Hypoxia promotes BMP signaling by retention of ACVR1
in the endosomal pathway
Rabaptin 5 is a direct effector of Rab5 in endocytic membrane
fusion. Because hypoxia causes Rabaptin 5 inhibition leading to
prolonged endosomal trafficking of EGF receptors through
association with Rab5,(9) we investigated whether hypoxia also
altered Rabaptin-5–mediated endosomal retention of mutant or
wild-type ACVR1. In C2C12 cells expressing V5-tagged wild-type
or mACVR1, we found that hypoxia enhanced retention of
mACVR1 in endosomes identified by the markers Rab5, EEA1
(Fig. 4A, B), and the transferrin receptor (Supplemental Fig. S9).
Supplemental Fig. S10 quantifies the greater endosomal co-
localization of V5-labeled mACVR1 under hypoxia compared
with either wild-type ACVR1 or cells under normoxic conditions.
Under hypoxia, cell surface ACVR1 receptor density is signifi-
cantly higher compared with normoxia, and this increase is also
intensified with FOP (Fig. 4C). Flow cytometry histograms for
each genotype-oxygen tension group are shown in Supple-
mental Fig. S11.
Both Rabaptin 5 mRNA (RABEP1) and protein levels were
decreased under hypoxic conditions, greater in FOP SHED cells
than in WT SHED cells (Fig. 4D, E). Because BMP signaling
occurs within endosomes,(28) and we found that the ACVR1
receptor is retained in endosomes under hypoxic conditions,
we performed a rescue experiment to determine whether
Rabaptin 5 decreased BMP signaling in the absence of
exogenous BMP ligand. When Rabaptin 5 was exogenously
expressed in FOP SHED cells, BMP signaling was markedly
decreased to normoxic levels (Fig. 4F, G), confirming that
hypoxia-mediated signaling occurred through ACVR1 in the
absence of exogenous BMP ligand and was the result of
altered endosomal retention of ACVR1.
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Fig. 2. The BMP signaling pathway is regulated by the cellular response to hypoxia. (A) SMAD 1/5/8 phosphorylation in SHED cells under hypoxia. SMAD
1/5/8 phosphorylation and HIF-1a were detected by Western blot analysis after the indicated number of hours under hypoxia (n¼ 5). (B) Relative ID1
expression in SHED cells under hypoxia. ID1 levels were quantified by real-time PCR and normalized to 18s RNA (n¼ 3). (C) Dorsomorphin, but not Noggin
or p38 MAPK inhibitor SB203580, mitigates SMAD 1/5/8 phosphorylation in SHED cells under low oxygen conditions. SMAD 1/5/8 phosphorylation was
detected by Western blot analysis after 2 hours under hypoxia. Noggin was used at 400 ng/mL (n¼ 3). (D) ID1 expression induced by hypoxia in SHED
cells is inhibited by Dorsomorphin, but not Noggin or p38 MAPK inhibitor SB203580. ID1 levels were quantified by real-time PCR and normalized to 18s
RNA (n¼ 3). C¼ unaffected controls; F¼ FOP. Genotype and hypoxia, as well as genotype and drug inhibition, are significantly related to SMAD 1/5/8
phosphorylation and ID1 expression by 2-way ANOVA (p< 0.0001). Bonferroni post hoc analysis: p< 0.0001; p< 0.001; p< 0.01; p< 0.05.
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Fig. 3. mACVR1 enhances chondrogenesis of SHED cells under hypoxia. (A) Representative chondrocyte pellets and quantification of chondrocyte pellet
size under the indicated conditions (n¼ 6). Scale bar¼ 1mm. (B) Histological appearance and quantification of extracellular matrix showing enhanced
chondrocyte differentiation (n¼ 3). Scale bar¼ 100mm. (C) Upregulation of chondrocyte markers COL2A1, Sox9, and aggrecan (ACAN) in SHED cells
under hypoxic conditions (n¼ 3). Genotype and hypoxia are significantly related to pellet size and chondrocyte extracellular matrix by 2-way ANOVA
(p< 0.01; interaction, p< 0.01). Post hoc analysis: p< 0.0001; p< 0.001; p< 0.01; p< 0.05.
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Fig. 4. Hypoxia promotes enhanced endosomal retention and BMP ligand-independent signaling of mACVR1. V5-tagged wild-type and mACVR1 is
localized to (A) EEA1-positive endosomes and (B) RAB5-positive endosomes on C2C12 cells (n¼ 9). Scale bar¼ 10mm. (C) There is an increased number of
cell surface-boundmACVR1 on SHED cells under hypoxic conditions (n¼ 9). RAB5 mRNA (RABEP1) (D) and RAB5 protein (E) levels were decreased under
hypoxic conditions, to a greater extent in FOP SHED cells compared with controls (n¼ 3). (F) Exogenous expression of Rabaptin 5 in FOP SHED cells
decreases BMP signaling in the absence of ligand (n¼ 2). C¼Control; F¼ FOP. Quantification of Western blot is shown to the right. Genotype and
hypoxia are significantly related to ACVR1 and RAB5 mRNA (RABEP1) as well as to Rabaptin-5 by 2-way ANOVA (p< 0.05). Post hoc analysis:
p< 0.0001; p< 0.01; p< 0.05.
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Inhibition of HIF-1a abrogates BMP ligand-independent
signaling and heterotopic ossification in a mouse model
of FOP
We used complementary genetic and chemical inhibitor
approaches to confirm the role of hypoxia in BMP ligand-
independent signaling. Adenovirus-Cre–induced deletion of
floxed HIF-1a in MEFs, but not adenovirus-GFP (negative
control), resulted in significantly reduced levels of SMAD1/5/8
phosphorylation (Fig. 5A). Similarly, using three potent HIF1-a
inhibitors, two currently available agents (apigenin and
imatinib)(29,30) and another highly specific agent but in early
clinical trials (PX-478),(31,32) BMP ligand-independent signaling
was blocked. Of note, and to our knowledge, HIF-1a is the only
molecular target shared by all three inhibitors. Thus, genetic
deletion or chemical inhibition of HIF-1a in MEFs or SHED cells,
respectively, prevented BMP ligand-independent signaling by
hypoxia.
Fig. 5B, C and Supplemental Fig. S12 show that each inhibitor
significantly reduced hypoxia-mediated SMAD1/5/8 phosphor-
ylation in both control and FOP SHED cells. Two potent, clinically
available, and nontoxic HIF1-a inhibitors (apigenin and imatinib)
were subsequently tested in a caACVR1 mouse model of FOP
and found to markedly reduce the formation of HEO (Fig. 5D)
and decrease the functional limitation about affected joints
(Fig. 5D).
PX-478 also markedly reduced HEO in the caACVR1 mouse
model (Supplemental Fig. S13).
Discussion
The response to tissue hypoxia is a critical regulatory signal in
embryogenesis, wound healing, and oncogenesis; however, its
mechanism of action in the pathophysiology of heterotopic
bone formation is unknown(8,9,17,20,33–35) We found that early
FOP lesions are profoundly hypoxic. Our data support that the
cellular response to hypoxia in FOP connective tissue progenitor
cells upregulates and prolongs BMP signaling through HIF-1a
repression of Rabaptin5-mediated early endosome fusion,
which regulates endosomal retention of BMP receptors.
The resultant retention of mACVR1 in the signaling endo-
somes amplifies and prolongs dysregulated BMP signaling
and stimulates HEO in an animal model of FOP. Rabaptin-5
overexpression or HIF-1a inhibition in vitro restores BMP
signaling to normoxic baseline levels in FOP cells, whereas
inhibition of HIF-1a in vivo profoundly inhibits HEO and joint
immobilization, the most debilitating features of FOP. Thus,
we provide evidence for a connection between endosomal
retention of mACVR1 under hypoxic conditions and a general
increase in BMP signaling (Fig. 4).
Endosomal retention of mACVR1 appears to be a major
contributor to hypoxia-mediated BMP signaling. We previously
reported that FOP cells fail to properly internalize BMP
receptors,(10) and our results showing an increase in cell surface
labeling of ACVR1 on FOP cells owing to a block in endosomal
transport is consistent with our previous findings. Compared
with wild-type receptor, mACVR1 displays lower FKBP12 binding
under hypoxic conditions, suggesting that basal (BMP ligand-
independent) activity in hypoxia is in part related to direct
receptor kinase inhibition. Although it is unclear if endosomal
retention of ACVR1 directly mediates increased cell surface
expression of the receptor as well as its decreased FKBP12
binding, this is supported by the effective abrogation of
BMP signaling after introduction of exogenous rabaptin-5 into
SHED cells.
Previous studies have shown that the cellular response to
hypoxia plays a critical role in regulating progenitor cell function
and facilitates the reprogramming process,(36–39) in part through
dysregulation of BMP signaling.(40–42) This finding is consistent
with the reprogramming activity previously demonstrated in
the early FOP lesional microenvironment.(40) Importantly, the
response to hypoxia also promotes cancer cell survival in
tumor formation. Recent studies have identified somatic gain-
of-functionmutations in ACVR1 in about a quarter of cases of the
childhood brainstem tumor diffuse intrinsic pontine gliomas
(DIPGs).(43–46) This intriguing finding suggests that dysregulated
BMP signaling may also confer protection against cell death in a
hypoxic microenvironment. Although ACVR1mutation-positive
cases were associated with younger patient age and longer
patient survival, the lack of cancer predisposition in FOP (where
identical mutations can be found), suggests that additional
driver mutations are necessary.(45,47)
Our findings allow us to construct a working schema of the
pathophysiology of flare-ups and resultant HEO in FOP (Fig. 6).
Generation of a hypoxic microenvironment in injured skeletal
muscle appears to be a critical step in the formation of HEO in
FOP. Studies show that dysregulated BMP signaling creates
an inflammatory and hypoxic microenvironment.(48–55) Inflam-
mation and hypoxia, acting through HIF-1a, downregulate
Rabaptin-5 (RABEP1) expression and cause retention of mACVR1
in signaling endosomes, where it amplifies and prolongs
BMP signaling with resultant HEO.(9,56,57) Enhanced BMP
signaling in FOP lesions is likely owing to both increased
endosomal retention of mACVR1 in hypoxic FOP lesional cells
and to increased basal BMP signaling relative to the wild-type
receptor.(5,25) This mechanism is also supported by a report
showing that receptor kinase activity affects FGFR3 trafficking
and determines the spatial segregation of signaling pathways,
suggesting that highly activated receptors increase signaling
capacity from intracellular compartments.(58) Taken together,
our data suggest that inflammation and tissue hypoxia
create a microenvironment that amplifies and prolongs BMP
signaling from mACVR1 and promotes ectopic chondrogenesis
and HEO in FOP.
Although our study focused on the hypoxic endosomal
retention of mACVR1 in the pathogenesis of episodic HEO in
FOP, one can speculate that the cellular response to hypoxia
may be more generalizable to other BMP receptors as well as
more common forms of HEO. In fact, the cellular response to
hypoxia noted with mACVR1 was also found with wild-type
ACVR1, albeit to a much lesser extent as one might expect with
endosomal retention of a well-regulated receptor.
It is a confounding observation that HEO in FOP is limited to
skeletal muscle, fascia, tendon, and ligaments. Although
highly speculative, the precise combination of inductive
factors, connective tissue progenitor cells, and microenviron-
mental factors may be lacking in other tissues. Further, there
are even exceptions to the notion that all skeletal muscles
behave similarly in FOP; for example, extra-ocular muscles, the
tongue, and the diaphragm are all spared from HEO in FOP.
However, under normal physiologic conditions, those muscles
do not fatigue or become hypoxic, perhaps explaining
their protection from HEO. This variation in skeletal muscles
may, in part, be related to the embryonic derivation and
gene expression profile of their resident stem cells,(59) and
understanding these differences could provide insight into
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Fig. 5. Inhibition of HIF-1a abrogates BMP ligand-independent signaling and heterotopic ossification in a FOP mouse model. (A) Adenovirus-
Cre–induced deletion of HIF-1a in wild-type MEF cells markedly reduces SMAD 1/5/8 phosphorylation (n¼ 3). (B) Apigenin or (C) imatinib blocks
BMP ligand-independent signaling in vitro (n¼ 3). (D) Apigenin or imatinib effectively reduces HEO and improves joint mobility in a caACVR1
FOP-like mouse model. Hypoxia and HIF-1a inhibition are significantly related to SMAD 1/5/8 phosphorylation and HEO by ANOVA (p< 0.01;
interaction, p< 0.05). Post hoc analysis: p< 0.0001; p< 0.001; p< 0.01; p< 0.05.
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mechanisms underlying the susceptibility of certain muscles
to HEO.
We have demonstrated that signaling in FOP lesion formation
has a BMP ligand-independent component and is mediated by
the SMAD 1/5/8 pathway under hypoxic conditions present in
both an injury-induced animal model of FOP and in lesions
from FOP patients. However, injury-induced inflammation is a
complex physiologic response to damaged tissue, including
infiltrating immune cells, progenitor cells, as well as secreted
cytokines and chemoattractants. Thus, while hypoxia mediates
BMP ligand-independent signaling, other responses in the local
microenvironment could be ligand-dependent and result in a
more complex regulation of ectopic chondrogenesis and HEO in
FOP. The mutant, but not wild-type, ACVR1 receptor transduces
signals from ligands of the activin family via BMP- not activin/
TGFb-responsive Smad effectors.(60,61) Although activin ligands
can assemble a ternary complex composed of a dual-specificity
type II receptor and wild-type ACVR1, a signal is not propagated,
hence actually act as antagonists of BMP signaling. In hypoxic
cells of FOP lesions, mACVR1 might indeed be retained and
aberrantly function in the endosomal pathway in a BMP
ligand-independent manner, however, as an activin-dependent
heterotetrameric signaling complex. Such a mechanism could
account for the disparate activities of wild-type and mACVR1
receptors during the hypoxia-dependent prolongation of
endosomal signaling reported here. We hypothesize that in
FOP, neither local secretion of activin family ligands nor hypoxia
within soft tissues would be sufficient to produce HEO; however,
both would be necessary.
We previously described an Acvr1 chimeric knock-in model
(Acvr1R206H/+) that recapitulated with great fidelity the pheno-
type found in FOP patients, including injury-induced flare-ups;
however, this model was very limited in that there was no
germline transmission.(62) The caAcvr1Q207D/+ model used in our
current work recapitulates the injury-induced flare-ups found in
patients with FOP and has been an accepted model to study
both FOP lesion formation and the response to specific
therapeutic interventions.(24,26) Although we did not use
mechanically based methods for trauma-induced HEO (eg,
blunt injury), we did use a highly reproducible chemically
induced method of muscle injury (ie, cardiotoxin injection). We
postulate that our findings here also have important implica-
tions for traumatic HEO.
That connective tissue hypoxia is a potent stimulus for HEO in
caAcvr1Q207D/+ mice is supported by a recent study in which
siRNA knockdown of HIF-1amRNA and-Runx2mRNA resulted in
inhibition of HEO in an Achilles tenotomy mouse model.(63) We
explored the use of available compounds to block HIF-1a
signaling and thus inhibit HEO in the FOP animal model.
Apigenin, a naturally occurring HIF-1a inhibitor found in
parsley,(29) was used to modulate dysregulated BMP signaling
in FOP connective tissue progenitor (SHED) cells and restore
BMP signaling to levels found in control SHED cells. Further-
more, apigenin was effective in abrogating HEO in a mouse
model of FOP. Imatinib, a receptor tyrosine kinase (RTK) inhibitor
that exhibits anti-angiogenic and anticancer properties, was also
used because of its potent HIF-1a inhibition.(30) Although
imatinib has off-target effects (such as those against PGDF), it
was selected because, unlike other available inhibitors, it has low
toxicity and the ability to inhibit HIF-1a without directly
affecting ACVR1 in vivo.(64) Our study shows that imatinib, like
apigenin, potently inhibits BMP pathway specific SMAD1/5/8
phosphorylation induced by HIF-1a in vitro, as well as HEO after
tissue injury in a mouse model of FOP. Interestingly, Compound
C (also known as Dorsomorphin), an AMP-activated kinase
(AMPK) and BMP type I receptor inhibitor, blocks hypoxic
activation of HIF-1a in vitro.(65) Although many agents inhibit
HIF-1a in cells, only a few have been shown to effectively
inhibit HIF-1a in vivo.(66,67) In all cases, it is possible that
these compounds also affect HEO by mechanisms other than
HIF-1a-SMAD cross-talk,(68) but more potent and highly specific
HIF-1a inhibitors such as PX-478, which was also highly effective
in our FOP mouse model, offer hope for the future.(31,32)
Althoughwe demonstrate that chemical inhibitors of HIF-1a can
block SMAD 1/5/8 phosphorylation in vitro and HEO in vivo,
direct genetic proof of HIF-1a involvement in HEO is lacking.
Although we have not explored the possibility of systemic
skeletal effects of imatinib or apigenin in the caAcvr1Q207D/+
mouse model, an in vivo analysis in adult mice after 8 weeks of
imatinib treatment demonstrated a decrease in osteoclast
activity, suggesting that imatinib may have therapeutic value as
an anti-osteolytic agent.(69) In healthy humans, there appears to
Fig. 6. Hypothetical schema for hypoxia-associated changes in BMP signaling in FOP. Inhibition of Rabaptin-5 by HIF-1a results in prolonged endosomal
retention of mACVR1 and enhanced BMP signaling.
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be no significant skeletal effects postnatally, and in patients
with chronic mylelogenous leukemia long-term therapy actually
promotes bone formation in the normotopic skeleton.(70)
Similarly, apigenin appears to be protective against bone loss,
especially in ovariectomized mice and rats.(71,72)
The evolutionary pressure for oxygen-sensitive regulation
of BMP signaling probably arose long before organisms
with endoskeletons appeared on Earth.(73–75) It is likely that
multicellular creatures of the pre-Cambrian world developed
and thrived in hypoxic sea beds where hypoxia-BMP pathway
interactions were extant and selective for morphogene-
sis.(76,77) Importantly, invertebrate Drosophila larvae develop
and live in a hypoxic microenvironment of rotting fruit in
which the BMP/Decapentaplegic (DPP) signaling pathway
functions to form and maintain the body plan and the
exoskeleton.(78) In addition, when the FOP mutation in
Saxophone, the Drosophila homologue of ACVR1, is intro-
duced into Drosophila, severe patterning malformations arise
and are amplified in a hypoxic microenvironment.(79) Interest-
ingly, Drosophila ema mutants, which are defective in endo-
somal membrane trafficking, accumulate BMP receptors and
phosphorylated Mad in their synapses.(12) This unexpected
finding supports that dysregulated endosomal retention of
BMP receptors causes hyperactive BMP signaling at the
neuromuscular junction,(12) a finding with critical implications
for common forms of HEO such as those that occur
sporadically after neurologic and soft tissue injury. These
observations strongly support our findings of the regulatory
role of the endosomal pathway in hypoxic BMP signaling.
In summary, our investigation supports that cellular oxygen
sensing is a critical regulator of HEO in FOP, knowledge that will
contribute to the development of more effective treatments for
FOP and possibly for related common disorders of heterotopic
ossification.
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